Clinical Trial Update: Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety study of hMN14 for colorectal cancer and breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• hMN14

Snippet

Sponsor: Gilead Sciences | Conditions: Colorectal Cancer, Colon Cancer | Phase 1, Phase 2 | Status: COMPLETED